Loading...
Please wait, while we are loading the content...
Similar Documents
Impact Of Sustained Weight Loss Achieved Through Gastric Gastric Sleeve Surgery With Circulating Level Of Obestatin Hormone In Iraqi Obese Subjects
| Content Provider | Semantic Scholar |
|---|---|
| Author | Razak A. Ghani M. Bch B. Sami, Ramiz Mukhtar M. Bch B. Muayad Abass Fadhel M. Bch B. |
| Copyright Year | 2014 |
| Abstract | Background: The epidemic of obesity is a major health problem in the developed world with a great influence on morbidity and mortality. Diet therapy, with and without support organizations, is relatively ineffective in treating obesity in the long term. Laparoscopic sleeve gastrectomy (LSG) has been introduced as a surgical option. Obestatin has been reported to have actions opposite to ghrelin, such as decreasing food intake, body weight, and delaying gastric emptying, and to antagonize the actions of ghrelin when both peptides are co administered. Aim of study: To evaluate serum obestatin levels achieved through sleeve gastrectomy and on insulin resistance and the serial changes of insulin concentration in obese patients and to determine the effect of weight loss after sleeve gastrectomy on free testosterone and sex hormone binding globulin levels and sexual quality of life in obese men and women. Subjects and methods: Twenty four patients undergone gastric sleeve surgery with 25 controls were selected. Body mass index, waist circumference (WC), lipid profile , fasting blood sugar, glycated hemoglobin (HbA1c), fasting insulin, QUICKI , free testosterone, sex hormone binding globulin and ghrelin hormone concentration were measured for patients prior gastric sleeve and for controls, another measures done one month and then three months post-surgery. Results:a significant decline were noticed in BMI, WC, TC, TG, LDL-cholesterol, fasting insulin, and ghrelin, with significant increase in QUICKI and SHBG in patient undergone gastric sleeve surgery with a significant differences in all studied parameters between patients and controls except free testosterone and SHBG. A significant negative correlation was shown between obestatin and BMI and between obestatin and fasting insulin in patients before sleeve gastrectomy. Conclusion: Bariatric surgery represents a promising treatment option in morbidly obese patients and low level of obestatinsuggested that this hormone is a nutritional marker reflecting body adiposity and insulin resistance. Key word: obesity, bariatric surgery, obestatin. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.iosrjournals.org/iosr-jac/papers/vol7-issue5/Version-1/G07513744.pdf |
| Alternate Webpage(s) | http://iosrjournals.org/iosr-jdms/papers/Vol13-issue5/Version-2/L013525460.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Appetite-Regulating Hormone Bariatric Surgery Blood Glucose Brain–computer interface Carotid Body Paraganglioma Cholesterol Eating GHRL gene Gastrectomy Gastric Emptying Globulins Gonadal Steroid Hormones Gonadorelin Hematological Disease How Much Distress Weight Loss How Often Weight Loss Human body weight Insulin Resistance Kidney Diseases Morbidity - disease rate Nothing up my sleeve number Obesity Patients Postgastrectomy Syndromes Sex Hormone-Binding Globulin Sleeve Lobectomy Stomach Neoplasms Sugars Surgical Procedures, Laparoscopic Testosterone Waist Circumference Writing Commons ghrelin |
| Content Type | Text |
| Resource Type | Article |
